Patient Case: Lepromatous Leprosy
A 50-year-old fisherman from a coastal region presents to a dermatology clinic with a gradual worsening of skin lesions over the past three years. He reports widespread, symmetrically distributed nodules and plaques on his face, arms, and legs. He also complains of nasal congestion, frequent nosebleeds, and thickening of his earlobes. Over time, he has developed progressive numbness in his hands and feet, making it difficult to handle fishing nets and tools.
On examination, the patient has multiple erythematous nodules and plaques on his face, including loss of eyebrows (madarosis) and thickened facial skin ("leonine facies"). There is bilateral thickening of the ulnar and common peroneal nerves, with decreased sensation in his extremities. A slit-skin smear reveals numerous acid-fast bacilli, and a skin biopsy confirms lepromatous leprosy with foamy histiocytes and globi of Mycobacterium leprae.
The patient is started on multidrug therapy (MDT) with rifampicin, dapsone, and clofazimine for at least 12 months, with continued monitoring for reactions such as erythema nodosum leprosum. He is also referred for nerve function assessment and rehabilitation to prevent disability. Contact tracing is initiated to screen his close family members for leprosy.
- Which clinical feature is most characteristic of lepromatous leprosy?
A) Single hypopigmented lesion with sensory loss
B) Multiple erythematous nodules and plaques with nerve involvement
C) Blistering rash with severe pruritus
D) Necrotic ulcers with purulent discharge - What is the significance of a positive slit-skin smear in lepromatous leprosy?
A) Indicates a high bacterial load and confirms multibacillary disease
B) Suggests the infection is resolving
C) Means the patient has a mixed bacterial and viral infection
D) Suggests a non-infectious inflammatory condition - What is the first-line treatment regimen for lepromatous leprosy?
A) Rifampicin and dapsone for 6 months
B) Rifampicin, dapsone, and clofazimine for at least 12 months
C) Isoniazid and rifampicin for 9 months
D) Metronidazole and azithromycin for 3 months - What is the major complication of untreated lepromatous leprosy?
A) Permanent nerve damage and severe disability
B) Rapid resolution of symptoms without treatment
C) Development of large abscesses with systemic infection
D) Spontaneous healing with minimal consequences
Answers
- Answer: B) Multiple erythematous nodules and plaques with nerve involvement
- Lepromatous leprosy is the multibacillary form of leprosy, characterized by widespread skin nodules, plaques, and significant nerve involvement. Single hypopigmented lesions with sensory loss (A) are typical of tuberculoid leprosy. Blistering rashes (C) and necrotic ulcers (D) are not associated with leprosy and suggest other infectious or dermatologic conditions.
- Answer: A) Indicates a high bacterial load and confirms multibacillary disease
- Lepromatous leprosy has a high bacterial burden, meaning slit-skin smears are strongly positive for acid-fast bacilli. This distinguishes it from paucibacillary forms like tuberculoid leprosy, which typically have negative smears. A positive smear does not indicate resolution (B) but rather active disease. It also does not suggest a mixed bacterial and viral infection (C) or a non-infectious condition (D).
- Answer: B) Rifampicin, dapsone, and clofazimine for at least 12 months
- Lepromatous leprosy requires a longer duration of multidrug therapy (MDT), typically at least 12 months, due to the high bacterial load. Rifampicin and dapsone alone (A) are used for tuberculoid leprosy. Isoniazid and rifampicin (C) are for tuberculosis, and metronidazole with azithromycin (D) are for bacterial infections, not leprosy.
- Answer: A) Permanent nerve damage and severe disability
- If untreated, lepromatous leprosy can lead to irreversible nerve damage, deformities, and disability, especially in the hands, feet, and face. The disease does not resolve on its own (B), nor does it typically cause systemic abscess formation (C). Without treatment, spontaneous healing (D) is rare, and progression is more common.
